TubPol Cancer Research Results

TubPol, tubulin polymerization: Click to Expand ⟱
Source:
Type:

Tubulin Polymerization — Assembly of α/β-tubulin heterodimers into microtubules. Microtubule polymerization and depolymerization are highly dynamic processes required for mitotic spindle formation, chromosome segregation, intracellular transport, maintenance of cell shape, and cellular migration.

Typical modulation in cancer: Both excessive stabilization and inhibition of tubulin polymerization can be anticancer because disruption of normal microtubule dynamics interferes with mitosis. Tubulin-polymerization inhibitors such as vinca alkaloids, colchicine-site binders, and benzimidazoles cause microtubule loss and mitotic arrest, whereas taxanes stabilize polymerized microtubules and prevent normal depolymerization. Therefore, direction must be interpreted according to the drug mechanism rather than assuming that ↑ or ↓ polymerization is universally favorable.

Typical modulation in Alzheimer’s disease: Microtubule destabilization contributes to impaired axonal transport and neuronal dysfunction. Tau normally stabilizes microtubules, and pathological tau disrupts microtubule organization. Thus, preservation of appropriate microtubule polymerization/dynamics may be neuroprotective, although excessive stabilization can also impair normal microtubule function.



Scientific Papers found: Click to Expand⟱
8655- MBZ,    Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells
- in-vitro, Melanoma, NA
TubPol↓, Apoptosis↑, TumCG↓, Bcl-2?, selectivity↑,
8652- MBZ,    Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors
- vitro+vivo, GBM, GL-15
TubPol↓, OS?, eff↑, PKA↓, *toxicity↓,
8648- MBZ,    Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
- Review, Var, NA
angioG↓, MMPs↓, MDR1↓, TubPol↓, RadioS?, ChemoSen?, TumCG↓, TumMeta?, OS↑, BioAv↓, BioAv↑, BBB↑, mitA↑, HH↓, Shh↓, Synergy↑, Gli1↓, PTCH2↓, XIAP↓, cl‑PARP↑, Casp3↑, BRAF↓, MEK↓, SYN1↑, Cyt‑c↑, TumVol↓, VEGFR2/KDR/Flk1↓, VEGF↓, VCAM-1↓, DYRK1B↓, QoL↑, Dose↝,

Showing Research Papers: 1 to 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death(tgid=5) ⓘ

Apoptosis↑, 1,   Bcl-2?, 1,   Casp3↑, 1,   Cyt‑c↑, 1,   XIAP↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

BRAF↓, 1,   DYRK1B↓, 1,   MEK↓, 1,   PKA↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

cl‑PARP↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

mitA↑, 1,   TubPol↓, 3,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Gli1↓, 1,   HH↓, 1,   PTCH2↓, 1,   Shh↓, 1,   TumCG↓, 2,  

Migration(tgid=13) ⓘ

MMPs↓, 1,   TumMeta?, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   VCAM-1↓, 1,   VEGF↓, 1,   VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

SYN1↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 1,   BioAv↑, 1,   ChemoSen?, 1,   Dose↝, 1,   eff↑, 1,   MDR1↓, 1,   RadioS?, 1,   selectivity↑, 1,   Synergy↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

BRAF↓, 1,  

Functional Outcomes(tgid=23) ⓘ

OS?, 1,   OS↑, 1,   QoL↑, 1,   TumVol↓, 1,  
Total Targets: 39

Pathway results for Effect on Normal Cells:


Functional Outcomes(tgid=23) ⓘ

toxicity↓, 1,  
Total Targets: 1

Scientific Paper Hit Count for: TubPol, tubulin polymerization
3 mebendazole
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1880  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page